Caveolin-1 modulates HIV-1 envelope-induced bystander apoptosis through gp41.
Human immunodeficiency virus (HIV) envelope (Env)-mediated bystander apoptosis is known to cause the progressive, severe, and irreversible loss of CD4(+) T cells in HIV-1-infected patients. Env-induced bystander apoptosis has been shown to be gp41 dependent and related to the membrane hemifusion between envelope-expressing cells and target cells. Caveolin-1 (Cav-1), the scaffold protein of specific membrane lipid rafts called caveolae, has been reported to interact with gp41. However, the underlying pathological or physiological meaning of this robust interaction remains unclear. In this report, we examine the interaction of cellular Cav-1 and HIV gp41 within the lipid rafts and show that Cav-1 modulates Env-induced bystander apoptosis through interactions with gp41 in SupT1 cells and CD4(+) T lymphocytes isolated from human peripheral blood. Cav-1 significantly suppressed Env-induced membrane hemifusion and caspase-3 activation and augmented Hsp70 upregulation. Moreover, a peptide containing the Cav-1 scaffold domain sequence markedly inhibited bystander apoptosis and apoptotic signal pathways. Our studies shed new light on the potential role of Cav-1 in limiting HIV pathogenesis and the development of a novel therapeutic strategy in treating HIV-1-infected patients.
Wang
Xiao Mei
XM
Department of Infectious Disease and Pathology, College of Veterinary Medicine, University of Florida, Gainesville, FL 32611, USA.
Nadeau
Peter E
PE
Lo
Yung-Tsun
YT
Mergia
Ayalew
A
D017209:Apoptosis; D015496:CD4-Positive T-Lymphocytes / Q000821:virology*; D051242:Caveolin 1 / Q000378:metabolism*; D002478:Cells, Cultured; D015700:HIV Envelope Protein gp41 / Q000378:metabolism*; D015497:HIV-1 / Q000472:pathogenicity*; D006801:Humans; D025941:Protein Interaction Mapping; D050378:T-Lymphocytes, Regulatory / Q000821:virology*
C495540:CAV1 protein, human; D051242:Caveolin 1; D015700:HIV Envelope Protein gp41; C514787:gp41 protein, Human immunodeficiency virus 1
J Virol. 2002 Sep;76(18):9152-64
12186899
Immunol Today. 1991 Apr;12(4):102-5
1676268
Cell Host Microbe. 2008 May 15;3(5):285-92
18474355
Annu Rev Immunol. 2003;21:457-81
12615889
Trends Immunol. 2002 Mar;23(3):158-64
11864845
J Virol. 2003 May;77(10):5846-54
12719578
Bioorg Med Chem Lett. 2008 Nov 15;18(22):5937-40
18667306
Virology. 2009 Mar 30;386(1):192-202
19185899
FASEB J. 2005 Apr;19(6):586-7
15665033
Virology. 2004 Nov 24;329(2):371-80
15518816
Blood. 1986 Jul;68(1):281-4
3013342
Immunity. 2004 Nov;21(5):617-27
15539149
Infect Immun. 2006 Dec;74(12):6665-74
16982844
Nat Med. 2000 Dec;6(12):1362-7
11100121
Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):11014-8
8855300
J Biol Chem. 2007 Jun 8;282(23):16899-906
17416587
J Virol. 2004 Sep;78(18):9697-704
15331702
J Virol. 1996 Jan;70(1):199-206
8523526
Cell Cycle. 2005 Nov;4(11):1599-607
16205123
Nature. 1998 Sep 10;395(6698):117, 119
9744265
J Exp Med. 1997 Jan 6;185(1):55-64
8996241
J Leukoc Biol. 2006 Feb;79(2):351-62
16330530
Annu Rev Microbiol. 2008;62:425-43
18785842
AIDS. 1999 May 28;13(8):909-17
10371171
J Virol. 2000 Jun;74(11):5347-51
10799612
Immunology. 2002 Feb;105(2):190-5
11872094
Mol Cell Biol. 2007 Nov;27(21):7703-17
17785436
Nat Rev Immunol. 2003 May;3(5):392-404
12766761
Science. 1998 Jun 19;280(5371):1884-8
9632381
Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12556-61
9770524
J Virol. 2006 Jun;80(11):5292-300
16699009
Blood. 2000 Nov 1;96(9):2951-64
11049971
Blood. 1997 Jul 15;90(2):745-53
9226175
Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9770-4
7937889
Blood. 1994 May 15;83(10):3101-3
7514053
Proteomics. 2007 Sep;7(17):3116-30
17676665
Nat Rev Immunol. 2003 Jul;3(7):557-68
12876558
Prim Care. 1998 Dec;25(4):759-74
9735117
Cell Mol Immunol. 2008 Feb;5(1):1-7
18318989
Cancer Lett. 2008 Sep 18;268(2):187-201
18482795
EMBO J. 1993 Apr;12(4):1597-605
8385608
Am J Respir Cell Mol Biol. 2006 Apr;34(4):434-42
16357362
Cell Mol Life Sci. 2008 Oct;65(20):3134-44
18500445
J Biol Chem. 2007 Mar 2;282(9):6143-52
17197700
Cell Death Differ. 2005 Aug;12 Suppl 1:916-23
15719026
AIDS. 1996 Jun;10(6):587-93
8780812
FEBS Lett. 2000 Jul 14;477(1-2):123-8
10899322
J Immunol. 2006 Oct 1;177(7):4853-60
16982927
AIDS Res Hum Retroviruses. 2009 Oct;25(10):943-50
19792869
Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):10909-13
8248193
J Exp Med. 1997 Feb 17;185(4):621-8
9034141
Curr Opin HIV AIDS. 2009 Mar;4(2):143-9
19339954
Antioxid Redox Signal. 2000 Fall;2(3):551-73
11229368
Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12676-80
7809100
Curr Top Microbiol Immunol. 1995;200:195-211
7634833
Cell Cycle. 2006 Aug;5(16):1865-71
16929183
J Virol. 2001 Aug;75(16):7637-50
11462036
Cell Signal. 1998 Jul;10(7):457-63
9754713
J Clin Invest. 1998 Jul 1;102(1):79-87
9649560
Cancer Cell. 2003 Jul;4(1):31-9
12892711
Biochim Biophys Acta. 2003 Jul 11;1614(1):36-50
12873764
Biochemistry. 2007 Feb 6;46(5):1398-401
17260969
J Virol. 1996 May;70(5):2982-91
8627774
J Exp Med. 1998 Mar 2;187(5):711-20
9480981
J Biol Chem. 2005 Jul 1;280(26):25134-45
15802273
Cell. 1992 Feb 21;68(4):673-82
1739974
Biochem Biophys Res Commun. 1998 Dec 18;253(2):382-7
9878546
Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):761-6
15637154
Virology. 2009 Mar 30;386(1):23-31
19178925
J Biol Chem. 1997 Mar 7;272(10):6525-33
9045678
J Cell Biol. 1992 Sep;118(5):1003-14
1512286
J Immunol. 1996 May 1;156(9):3509-20
8617980
FEBS Lett. 1995 Nov 13;375(1-2):11-4
7498456